Inhaled Hypertonic Saline Use in the Emergency Department to Treat Acute Viral Bronchiolitis
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Acute viral bronchiolitis is an extremely common childhood disease, responsible for
approximately 17% of childhood admissions to hospital per year, with an annually cost that
reaches U$ 500 million.
Despite being a well known disease among pediatricians, there are few, if any, effective
treatment options apart from oxygen supplementation and adequate hydration.
The purpose of this study is to determine wether nebulized hypertonic saline (3%) is more
effective than normal saline (0,9%) when used in repeated doses during the first 24 hours of
in-hospital treatment.